-
Mashup Score: 16Knowledge Bowl - 25 day(s) ago
In the ACR Convergence Knowledge Bowl, rheumatology fellows compete in a Jeopardy style game with questions on rheumatic and musculoskeletal disease topics.
Source: rheumatology.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4ICYMI: Here at Last: Treatment Options for VEXAS | RheumNow - 5 month(s) ago
We have known about the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome for nearly 3 years, but there has been relatively little to say about how to treat it. To date there have been over twice as many publications about VEXAS (263 publications) as there have been patients described with respect to treatment strategies (116 patients). One of the late breaking abstracts may finally have rectified this imbalance.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4ICYMI: Here at Last: Treatment Options for VEXAS | RheumNow - 5 month(s) ago
We have known about the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome for nearly 3 years, but there has been relatively little to say about how to treat it. To date there have been over twice as many publications about VEXAS (263 publications) as there have been patients described with respect to treatment strategies (116 patients). One of the late breaking abstracts may finally have rectified this imbalance.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 13
An expert panel on lupus treatment highlighted the 2023 update to the EULAR recommendations for the management of systemic lupus erythematosus. Maria Dall’Era, MD, Richard Furie, MD, and Marta Mosca, MD, PhD, led the discussion using patient cases to illustrate how to manage the challenges lupus can present.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 22
Doruk Erkan, MD, MPH, and Jason S. Knight, MD, PhD, explained the antiphospholipid syndrome classification criteria developed by the ACR and EULAR, including clinical features, risk stratification of macrovascular events, re-defined pregnancy morbidity definitions, and more.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 5New ACR Guidelines for Screening, Monitoring, and Treatment of SARD-ILD in Focus - ACR Convergence Today - 6 month(s) ago
Panelists provided insight into the forthcoming ACR guidelines on systemic autoimmune rheumatic disease associated with interstitial lung disease. Sindhu R. Johnson, MD, PhD, discussed some of the 50 recommendations in the guideline.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3Experts Review Nervous System Manifestations in Sjögren's Syndrome - ACR Convergence Today - 6 month(s) ago
Brent P. Goodman, MD, Arun D. Varadhachary, MD, PhD, and Julius Birnbaum, MD, discussed the challenging complications of the nervous system that can present in patients with Sjögren’s syndrome, as well as practical strategies for the management of them.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3Panelists Discuss How and When to Safely Use Steroids in RA - ACR Convergence Today - 6 month(s) ago
Rheumatologists may be tempted to use steroids in patients with very active disease as they wait for a disease-modifying antirheumatic drug to take effect. But Vivian Bykerk, MD, cautioned in a Meet the Panel session that this strategy can be counterproductive.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 8Healthcare Providers Discuss Compassion for Self and Others — How to Practice It and How to Teach It - ACR Convergence Today - 6 month(s) ago
Self-compassion is a way to protect against burnout for healthcare professionals. Vaneet Sandhu, MD, MS, RhMSUS, explained how compassion fatigue and fear of compassion are related, and how to incorporate compassion curriculum into healthcare training.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 16Dermatologist Shares Efficacy of Monoclonal Antibody for Treatment of Lupus Rashes - ACR Convergence Today - 6 month(s) ago
Anifrolumab gained U.S. Food and Drug Administration approval for use in systemic lupus in 2021, and the drug has had positive results among adults and adolescents with recalcitrant cutaneous lupus erythematosus, too. Katharina S. Shaw, MD, reviewed commonly observed rashes in rheumatologic patients and how to treat them.
Source: www.acrconvergencetoday.orgCategories: General Medicine News, RheumatologyTweet
The #ACR23 Knowledge Bowl teams have been confirmed! Get ready to cheer on your favorite teams in person in San Diego during the preliminary round, Nov. 12, 1:00—3:00 PM PT, & concluding with the final round, Nov. 13, 1:00—3:00 PM PT. View the teams → https://t.co/1NyMmEN7Fc https://t.co/w6zCS6DrQt